Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias - PubMed (original) (raw)

. 1997 Mar 20;14(11):1259-68.

doi: 10.1038/sj.onc.1201099.

Affiliations

• PMID: 9178886
• DOI: 10.1038/sj.onc.1201099

Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias

H Yi et al. Oncogene. 1997.

Abstract

Two ets family members, namely erg and Fli-1 are fused with two EWS family members namely EWS and TLS/FUS as a result of chromosome translocation in human solid tumors and leukemias. EWS-erg and EWS-Fli-1, which are involved in greater than 95% of Ewing family of tumors, were shown to function as transcriptional activators. TLS/FUS-erg, which is involved in human myeloid leukemias also functions as a transcriptional activator. Expression of these fusion proteins (EWS-erg and EWS-Fli-1) are shown to be essential for maintaining the oncogenic and tumorigenic properties of tumor cells. Cancer is thought to be caused not only by uncontrolled cell proliferation but also by deregulation of programmed cell death. Therefore, we have studied the role of normal (Fli-1 and erg) and aberrant fusion proteins (EWS-erg, EWS-Fli-1 and TLS/FUS-erg) in apoptosis. We have found that expression of normal (Fli-1 and erg) and aberrant fusion proteins inhibit the apoptosis of NIH3T3 cells induced by either serum deprivation or by treatment with calcium ionophore. We have also observed similar suppression of apoptosis in Ewing's sarcoma cells expressing EWS-Fli-1 and EWS-erg proteins suggesting that these fusion proteins may be responsible for the decreased ability of these tumor cells to undergo apoptosis. Inhibition of the expression of these aberrant fusion proteins by antisense RNA technique resulted in increased susceptibility to apoptosis leading to the death of tumor cells. Therefore, our results suggest that one can use therapeutic agents which can down regulate the expression of fusion proteins in combination with chemotherapeutic agents as an effective treatment for these human solid tumors and leukemias.

PubMed Disclaimer

Similar articles

• A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
  Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. Sorensen PH, et al. Nat Genet. 1994 Feb;6(2):146-51. doi: 10.1038/ng0294-146. Nat Genet. 1994. PMID: 8162068
• EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
  Kovar H, Aryee DN, Jug G, Henöckl C, Schemper M, Delattre O, Thomas G, Gadner H. Kovar H, et al. Cell Growth Differ. 1996 Apr;7(4):429-37. Cell Growth Differ. 1996. PMID: 9052984
• EWS/Fli-1 chimeric protein is a transcriptional activator.
  Ohno T, Rao VN, Reddy ES. Ohno T, et al. Cancer Res. 1993 Dec 15;53(24):5859-63. Cancer Res. 1993. PMID: 7503813
• The role of Fli-1 in normal cell function and malignant transformation.
  Truong AH, Ben-David Y. Truong AH, et al. Oncogene. 2000 Dec 18;19(55):6482-9. doi: 10.1038/sj.onc.1204042. Oncogene. 2000. PMID: 11175364 Review.
• The Biology of Ewing sarcoma.
  Riggi N, Stamenkovic I. Riggi N, et al. Cancer Lett. 2007 Aug 28;254(1):1-10. doi: 10.1016/j.canlet.2006.12.009. Epub 2007 Jan 23. Cancer Lett. 2007. PMID: 17250957 Review.

Cited by

• ERG Functionally Overlaps with Other Ets Proteins in Promoting TH9 Cell Expression of Il9 during Allergic Lung Inflammation.
  Kharwadkar R, Ulrich BJ, Chu M, Koh B, Hufford MM, Fu Y, Birdsey GM, Porse BT, Randi AM, Kaplan MH. Kharwadkar R, et al. J Immunol. 2023 Mar 1;210(5):537-546. doi: 10.4049/jimmunol.2200113. J Immunol. 2023. PMID: 36637217 Free PMC article.
• TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
  Zhang H, Zhan Q, Wang X, Gao F, Yu J, Wang J, Fu W, Wang P, Wei X, Zhang L. Zhang H, et al. Ann Hematol. 2022 Dec;101(12):2583-2600. doi: 10.1007/s00277-022-04979-5. Epub 2022 Oct 1. Ann Hematol. 2022. PMID: 36181538 Free PMC article. Review.
• Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans.
  Hasina Z, Wang N, Wang CC. Hasina Z, et al. Front Cell Dev Biol. 2022 May 23;10:877711. doi: 10.3389/fcell.2022.877711. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35676933 Free PMC article. Review.
• Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis.
  Rahman MR, Islam T, Nicoletti F, Petralia MC, Ciurleo R, Fisicaro F, Pennisi M, Bramanti A, Demirtas TY, Gov E, Islam MR, Mussa BM, Moni MA, Fagone P. Rahman MR, et al. Genes (Basel). 2021 Feb 7;12(2):237. doi: 10.3390/genes12020237. Genes (Basel). 2021. PMID: 33562405 Free PMC article.
• A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.
  Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, Song W, Li X, Li L, Du Z, Jia L, Zhou L, Li W, Hoffman AR, Hu JF, Cui J. Chen N, et al. Genome Biol. 2018 Dec 11;19(1):218. doi: 10.1186/s13059-018-1594-y. Genome Biol. 2018. PMID: 30537986 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information